Skip to main content
Pharmaceutical product and formulation background
Pharmaceutical Division

Levoketeconazole

Levoketeconazole is used to treat Cushing syndrome by inhibiting cortisol production.

Cushing syndromeCAS 65277-42-1
✓Quality Assured
✓Steroidogenesis inhibitor
✓Bulk Supply

Detailed technical, regulatory, and supply information is available for commercial evaluation.

Technical Overview

Levoketeconazole – CAS 65277-42-1

CAS Number

65277-42-1

Category

Cushing syndrome

Therapeutic Class

Steroidogenesis inhibitor

Description

Levoketeconazole is used to treat Cushing syndrome by inhibiting cortisol production.

Applications

  • Cushing syndrome
  • Hypercortisolism

Handling & Supply Details

Packaging

Standard export packaging in double-lined HDPE drums or fiber drums with inner poly liners; custom pack sizes available on request.

Product Inquiry

Disclaimer

Products offered are intended strictly for R&D, registration and/or export purposes only. The responsibility for ensuring that the product does not infringe any third-party patent or intellectual property rights in the destination country rests solely with the buyer.

This website uses cookies to optimize your navigation and adapt to your preferences. You can continue browsing without accepting. If you select "Accept", you accept the use of ALL cookies. You can also select cookies in "Cookie settings" and consult our Cookies Policy and Privacy Policy here.